Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma

Published:2009-02-01 Issue:3 Volume:124 Page:578-588
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Feng Yan-Bin,Lin De-Chen,Shi Zhi-Zhou,Wang Xiao-Chun,Shen Xiao-Ming,Zhang Yu,Du Xiao-Li,Luo Man-Li,Xu Xin,Han Ya-Ling,Cai Yan,Zhang Zi-Qiang,Zhan Qi-Min,Wang Ming-Rong

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference41 articles.

1. Targeting polo-like kinase 1 for cancer therapy;Strebhardt;Nat Rev Cancer,2006

2. Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation;Ando;J Biol Chem,2004

3. Polo-like kinase 1 and Chk2 interact and co-localize to centrosomes and the midbody;Tsvetkov;J Biol Chem,2003

4. Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase;Toyoshima-Morimoto;Nature,2001

5. Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase;Smith;Biochem Biophys Res Commun,1997

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating network analysis with differential expression to uncover therapeutic and prognostic biomarkers in esophageal squamous cell carcinoma;Frontiers in Molecular Biosciences;2024-08-21

2. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer;Biomedicine & Pharmacotherapy;2024-07

3. HuaChanSu suppresses the growth of hepatocellular carcinoma cells by interfering with pentose phosphate pathway through down-regulation of G6PD enzyme activity and expression;Heliyon;2024-02

4. The oncogenic mechanisms of the Janus kinase-signal transducer and activator of transcription pathway in digestive tract tumors;Cell Communication and Signaling;2024-01-25

5. Development of MPS1 Inhibitors: Recent Advances and Perspectives;Journal of Medicinal Chemistry;2023-12-14